Cite
Meyer S, Vogt T, Landthaler M, et al. Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Res. 2009;2009:848645doi: 10.1155/2010/848645.
Meyer, S., Vogt, T., Landthaler, M., Berand, A., Reichle, A., Bataille, F., Marx, A. H., Menz, A., Hartmann, A., Kunz-Schughart, L. A., & Wild, P. J. (2009). Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR research, 2009848645. https://doi.org/10.1155/2010/848645
Meyer, Stefanie, et al. "Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma." PPAR research vol. 2009 (2009): 848645. doi: https://doi.org/10.1155/2010/848645
Meyer S, Vogt T, Landthaler M, Berand A, Reichle A, Bataille F, Marx AH, Menz A, Hartmann A, Kunz-Schughart LA, Wild PJ. Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Res. 2009;2009:848645. doi: 10.1155/2010/848645. Epub 2009 Jul 20. PMID: 19639032; PMCID: PMC2712952.
Copy
Download .nbib